{"entity":{"type":"insider","cik":"0001784487","url":"/insider/0001784487","json_url":"/insider/0001784487.json","name":"Lunger John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":21,"first":"2020-01-07","last":"2025-01-17","span_basis":"filed_date"},"name_variants":[{"name":"Lunger John","source":"filing","n_filings":21,"first_seen":"2020-01-07","last_seen":"2025-01-17"}],"transactions":[{"id":4955250,"accession":"0001104659-25-004607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-004607","line_url":"/filing/0001104659-25-004607#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5584.0,"shares_display":"5,584","price_per_share":0.5808,"price_display":"0.58","price_state":"stated","total_value":3243.1872,"total_display":"3,243.19","total_whole":"3,243","shares_owned_after":7510.0,"shares_owned_after_display":"7,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-17","scope":"insider"},{"id":4665333,"accession":"0001104659-25-003768","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-003768","line_url":"/filing/0001104659-25-003768#line-3","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9803.0,"shares_display":"9,803","price_per_share":0.5748,"price_display":"0.57","price_state":"stated","total_value":5634.7644,"total_display":"5,634.76","total_whole":"5,635","shares_owned_after":13756.0,"shares_owned_after_display":"13,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-15","scope":"insider"},{"id":4665328,"accession":"0001104659-25-003768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-003768","line_url":"/filing/0001104659-25-003768","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9739.0,"shares_display":"9,739","price_per_share":0.5879,"price_display":"0.59","price_state":"stated","total_value":5725.5581,"total_display":"5,725.56","total_whole":"5,726","shares_owned_after":7623.0,"shares_owned_after_display":"7,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider","n_lines":2},{"id":2128727,"accession":"0001104659-24-004562","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-004562","line_url":"/filing/0001104659-24-004562","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18114.0,"shares_display":"18,114","price_per_share":0.673,"price_display":"0.67","price_state":"stated","total_value":12190.722,"total_display":"12,190.72","total_whole":"12,191","shares_owned_after":19015.0,"shares_owned_after_display":"19,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-17","scope":"insider","n_lines":2},{"id":2128719,"accession":"0001104659-24-004562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-004562","line_url":"/filing/0001104659-24-004562#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4681.0,"shares_display":"4,681","price_per_share":0.79,"price_display":"0.79","price_state":"stated","total_value":3697.99,"total_display":"3,697.99","total_whole":"3,698","shares_owned_after":7023.0,"shares_owned_after_display":"7,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":2555166,"accession":"0001104659-24-003744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-003744","line_url":"/filing/0001104659-24-003744#line-2","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5220.0,"shares_display":"5,220","price_per_share":0.8541,"price_display":"0.85","price_state":"stated","total_value":4458.402,"total_display":"4,458.40","total_whole":"4,458","shares_owned_after":7874.0,"shares_owned_after_display":"7,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-12","scope":"insider"},{"id":2555160,"accession":"0001104659-24-003744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-003744","line_url":"/filing/0001104659-24-003744#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4009.0,"shares_display":"4,009","price_per_share":0.8367,"price_display":"0.84","price_state":"stated","total_value":3354.3303,"total_display":"3,354.33","total_whole":"3,354","shares_owned_after":6104.0,"shares_owned_after_display":"6,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider"},{"id":7891483,"accession":"0001104659-23-086416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-086416","line_url":"/filing/0001104659-23-086416#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3096.0,"shares_display":"3,096","price_per_share":0.9056,"price_display":"0.91","price_state":"stated","total_value":2803.7376,"total_display":"2,803.74","total_whole":"2,804","shares_owned_after":4718.0,"shares_owned_after_display":"4,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-01","scope":"insider"},{"id":8521473,"accession":"0001104659-23-004382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-004382","line_url":"/filing/0001104659-23-004382#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4440.0,"shares_display":"4,440","price_per_share":1.858,"price_display":"1.86","price_state":"stated","total_value":8249.52,"total_display":"8,249.52","total_whole":"8,250","shares_owned_after":7264.0,"shares_owned_after_display":"7,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-17","scope":"insider"},{"id":8014248,"accession":"0001104659-23-003538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-003538","line_url":"/filing/0001104659-23-003538#line-2","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4973.0,"shares_display":"4,973","price_per_share":1.706,"price_display":"1.71","price_state":"stated","total_value":8483.938,"total_display":"8,483.94","total_whole":"8,484","shares_owned_after":8121.0,"shares_owned_after_display":"8,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-12","scope":"insider"},{"id":8014246,"accession":"0001104659-23-003538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-003538","line_url":"/filing/0001104659-23-003538#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3843.0,"shares_display":"3,843","price_per_share":1.7468,"price_display":"1.75","price_state":"stated","total_value":6712.9524,"total_display":"6,712.95","total_whole":"6,713","shares_owned_after":6270.0,"shares_owned_after_display":"6,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":7965558,"accession":"0001104659-23-001090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-001090","line_url":"/filing/0001104659-23-001090#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":1.694,"price_display":"1.69","price_state":"stated","total_value":1863.4,"total_display":"1,863.40","total_whole":"1,863","shares_owned_after":1725.0,"shares_owned_after_display":"1,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-04","scope":"insider"},{"id":6814494,"accession":"0001104659-22-084894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-084894","line_url":"/filing/0001104659-22-084894#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2983.0,"shares_display":"2,983","price_per_share":1.7735,"price_display":"1.77","price_state":"stated","total_value":5290.3505,"total_display":"5,290.35","total_whole":"5,290","shares_owned_after":4829.0,"shares_owned_after_display":"4,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-01","scope":"insider"},{"id":6307478,"accession":"0001104659-22-077470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-077470","line_url":"/filing/0001104659-22-077470#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1973.0,"shares_display":"1,973","price_per_share":1.6781,"price_display":"1.68","price_state":"stated","total_value":3310.8913,"total_display":"3,310.89","total_whole":"3,311","shares_owned_after":3104.0,"shares_owned_after_display":"3,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-05","scope":"insider"},{"id":6146791,"accession":"0001104659-22-005055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-005055","line_url":"/filing/0001104659-22-005055#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4368.0,"shares_display":"4,368","price_per_share":3.1918,"price_display":"3.19","price_state":"stated","total_value":13941.7824,"total_display":"13,941.78","total_whole":"13,942","shares_owned_after":7336.0,"shares_owned_after_display":"7,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6267183,"accession":"0001104659-22-004152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-004152","line_url":"/filing/0001104659-22-004152#line-2","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1076.0,"shares_display":"1,076","price_per_share":3.5441,"price_display":"3.54","price_state":"stated","total_value":3813.4516,"total_display":"3,813.45","total_whole":"3,813","shares_owned_after":1749.0,"shares_owned_after_display":"1,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-12","filed_date":"2022-01-13","scope":"insider"},{"id":6267181,"accession":"0001104659-22-004152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-004152","line_url":"/filing/0001104659-22-004152#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3770.0,"shares_display":"3,770","price_per_share":3.5567,"price_display":"3.56","price_state":"stated","total_value":13408.759,"total_display":"13,408.76","total_whole":"13,409","shares_owned_after":6343.0,"shares_owned_after_display":"6,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider"},{"id":6351099,"accession":"0001104659-22-001670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-001670","line_url":"/filing/0001104659-22-001670#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1070.0,"shares_display":"1,070","price_per_share":4.0642,"price_display":"4.06","price_state":"stated","total_value":4348.694,"total_display":"4,348.69","total_whole":"4,349","shares_owned_after":1755.0,"shares_owned_after_display":"1,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":4948649,"accession":"0001104659-21-098959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-098959","line_url":"/filing/0001104659-21-098959#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2939.0,"shares_display":"2,939","price_per_share":3.5848,"price_display":"3.58","price_state":"stated","total_value":10535.7272,"total_display":"10,535.73","total_whole":"10,536","shares_owned_after":4873.0,"shares_owned_after_display":"4,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-02","scope":"insider"},{"id":4876644,"accession":"0001104659-21-089048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-089048","line_url":"/filing/0001104659-21-089048#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1907.0,"shares_display":"1,907","price_per_share":4.2649,"price_display":"4.26","price_state":"stated","total_value":8133.1643,"total_display":"8,133.16","total_whole":"8,133","shares_owned_after":3170.0,"shares_owned_after_display":"3,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-02","scope":"insider"},{"id":4986865,"accession":"0001104659-21-005545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-005545","line_url":"/filing/0001104659-21-005545#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4358.0,"shares_display":"4,358","price_per_share":5.6695,"price_display":"5.67","price_state":"stated","total_value":24707.681,"total_display":"24,707.68","total_whole":"24,708","shares_owned_after":7346.0,"shares_owned_after_display":"7,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-19","scope":"insider"},{"id":4514057,"accession":"0001104659-21-003592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-003592","line_url":"/filing/0001104659-21-003592#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1058.0,"shares_display":"1,058","price_per_share":6.1522,"price_display":"6.15","price_state":"stated","total_value":6509.0276,"total_display":"6,509.03","total_whole":"6,509","shares_owned_after":1767.0,"shares_owned_after_display":"1,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-12","scope":"insider"},{"id":4129373,"accession":"0001104659-21-001178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-001178","line_url":"/filing/0001104659-21-001178#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1065.0,"shares_display":"1,065","price_per_share":5.3279,"price_display":"5.33","price_state":"stated","total_value":5674.2135,"total_display":"5,674.21","total_whole":"5,674","shares_owned_after":1760.0,"shares_owned_after_display":"1,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":3043434,"accession":"0001104659-20-090470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-090470","line_url":"/filing/0001104659-20-090470#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4823.0,"shares_display":"4,823","price_per_share":9.25,"price_display":"9.25","price_state":"stated","total_value":44612.75,"total_display":"44,612.75","total_whole":"44,613","shares_owned_after":8066.0,"shares_owned_after_display":"8,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-04","scope":"insider"},{"id":3328240,"accession":"0001104659-20-004421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-004421","line_url":"/filing/0001104659-20-004421#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1144.0,"shares_display":"1,144","price_per_share":5.1347,"price_display":"5.13","price_state":"stated","total_value":5874.0968,"total_display":"5,874.10","total_whole":"5,874","shares_owned_after":1681.0,"shares_owned_after_display":"1,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-14","filed_date":"2020-01-15","scope":"insider"},{"id":2911385,"accession":"0001104659-20-002082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-002082","line_url":"/filing/0001104659-20-002082#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001784487","owner_name":"Lunger John","owner_display_name":"Lunger John","owner_url":"/insider/0001784487","role":"Officer (Chief Patient Supply Officer)","role_mark":"O","role_mark_label":"Officer (Chief Patient Supply Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Patient Supply Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1148.0,"shares_display":"1,148","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":1377.6,"total_display":"1,377.60","total_whole":"1,378","shares_owned_after":1677.0,"shares_owned_after_display":"1,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Officer (Chief Patient Supply Officer)","n_filings":21,"first_seen":"2020-01-07","last_seen":"2025-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001784487","retrieved_at":"2026-08-22T07:30:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}